Originally presented at Global MPS Day 2023
In this on-demand webinar, Heidrun Ellinger, Ph.D., of Bayer talks with Emulate Principal Scientist Sasha Berdichevski about a phase two clinical trial that was voluntarily withdrawn due to a liver toxicity signal.